We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current KRBP market cap is 755.08k. The company's latest EPS is USD -27.5980 and P/E is -0.02.
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -8.43M | -8.4M | -6.92M | -4.78M | -4.29M |
| Net Income | -8.44M | -11.86M | -7.07M | -5.3M | -6.77M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.18M | -3.71M | -19.2M | -25.31M | -31.11M |
| Net Income | -3.82M | -3.73M | -19.2M | -25.59M | -34.73M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 19.52M | 13.02M | 11.97M | 13.11M | 13.64M |
| Total Liabilities | 7.74M | 12.74M | 17.74M | 21.25M | 19.93M |
| Total Equity | 11.78M | 284k | -5.78M | -8.14M | -6.3M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 876k | 2.65M | 12.83M | 30.73M | 11.97M |
| Total Liabilities | 611k | 674k | 1.47M | 3.41M | 17.74M |
| Total Equity | 265k | 1.98M | 11.36M | 27.32M | -5.78M |
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -13.55M | -19.64M | -23.75M | -4.13M | -10.59M |
| Investing | -4.96M | -4.82M | -4.87M | N/A | N/A |
| Financing | -340k | -455k | 3.9M | 5.54M | 12.65M |
| Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -2.15M | -2.91M | -6.13M | -20.32M | -23.75M |
| Investing | -138k | -303k | -1.46M | -1.81M | -4.87M |
| Financing | 1.63M | 4.76M | 15.81M | 37.34M | 3.9M |
| Market Cap | 755.08k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 1.17 |
| Price to Book Ratio | -0.13 |
| Dividend Yield | - |
| Shares Outstanding | 1.26M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -92.12% |
| 52 Week High | 9.30 |
| 52 Week Low | 0.51 |
| Spread (Intraday) | 0.14 (20.37%) |
| Company Name | Kiromic BioPharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://kiromic.com/ |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
|
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: 1-888-992-3836 | help@advfn.com |
| ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
| ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
| ADVFN France ADVFN US ADVFN Korea |
